Cargando…

Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study

INTRODUCTION: Overweight and obese women may require higher doses of gonadotrophin when undergoing In Vitro Fertilization Treatment (IVF). Consequently, one may expect a sub-optimal oocyte retrieval in the first treatment cycle and thus a larger compensation in gonadotrophin-dose in the following tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Mette Wulf, Ingerslev, Hans Jakob, Degn, Birte, Kesmodel, Ulrik Schiøler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031400/
https://www.ncbi.nlm.nih.gov/pubmed/27654907
http://dx.doi.org/10.1371/journal.pone.0163393
_version_ 1782454803041878016
author Christensen, Mette Wulf
Ingerslev, Hans Jakob
Degn, Birte
Kesmodel, Ulrik Schiøler
author_facet Christensen, Mette Wulf
Ingerslev, Hans Jakob
Degn, Birte
Kesmodel, Ulrik Schiøler
author_sort Christensen, Mette Wulf
collection PubMed
description INTRODUCTION: Overweight and obese women may require higher doses of gonadotrophin when undergoing In Vitro Fertilization Treatment (IVF). Consequently, one may expect a sub-optimal oocyte retrieval in the first treatment cycle and thus a larger compensation in gonadotrophin-dose in the following treatment-cycles and a more favorable outcome. The main objective was to explore if treatment cycle number modifies the outcome when investigating the effect of female Body Mass Index (BMI) on oocyte quantity in IVF. MATERIAL AND METHODS: A historical cohort study was conducted on 5,342 treatment-cycles during the period 1999–2009. Exclusion criteria were missing information on BMI or treatment type. Further, women were excluded if they had ovulated before oocyte retrieval. According to baseline BMI, women were divided into four categories following the World Health Organization standards. Multiple linear regressions analyses were performed accounting for the non-independence of ≥2 cycles in a woman. RESULTS: Stratification according to cycle number revealed a more suboptimal outcome in the first treatment- cycles than in the following cycles, suggesting a possible interaction or effect modification from cycle number or a factor related to cycle number. The median dose of total follicular stimulating hormone given to the four BMI groups could not straight forwardly explain the less optimal oocyte outcome observed in first treatment cycles. No statistically significant differences were observed in oocyte yield for underweight, overweight and obesity compared to normal weight women when analyzing all treatment-cycles. Overweight women had significantly fewer mature (MII) oocytes (p = 0.009) than normal weight women, whereas no differences was observed for underweight and obese women. CONCLUSION: Our study suggests a possible interaction or effect modification related to treatment cycle number. Investigating the effects of BMI on IVF-results in first treatment-cycles alone should be carried out cautiously.
format Online
Article
Text
id pubmed-5031400
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50314002016-10-10 Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study Christensen, Mette Wulf Ingerslev, Hans Jakob Degn, Birte Kesmodel, Ulrik Schiøler PLoS One Research Article INTRODUCTION: Overweight and obese women may require higher doses of gonadotrophin when undergoing In Vitro Fertilization Treatment (IVF). Consequently, one may expect a sub-optimal oocyte retrieval in the first treatment cycle and thus a larger compensation in gonadotrophin-dose in the following treatment-cycles and a more favorable outcome. The main objective was to explore if treatment cycle number modifies the outcome when investigating the effect of female Body Mass Index (BMI) on oocyte quantity in IVF. MATERIAL AND METHODS: A historical cohort study was conducted on 5,342 treatment-cycles during the period 1999–2009. Exclusion criteria were missing information on BMI or treatment type. Further, women were excluded if they had ovulated before oocyte retrieval. According to baseline BMI, women were divided into four categories following the World Health Organization standards. Multiple linear regressions analyses were performed accounting for the non-independence of ≥2 cycles in a woman. RESULTS: Stratification according to cycle number revealed a more suboptimal outcome in the first treatment- cycles than in the following cycles, suggesting a possible interaction or effect modification from cycle number or a factor related to cycle number. The median dose of total follicular stimulating hormone given to the four BMI groups could not straight forwardly explain the less optimal oocyte outcome observed in first treatment cycles. No statistically significant differences were observed in oocyte yield for underweight, overweight and obesity compared to normal weight women when analyzing all treatment-cycles. Overweight women had significantly fewer mature (MII) oocytes (p = 0.009) than normal weight women, whereas no differences was observed for underweight and obese women. CONCLUSION: Our study suggests a possible interaction or effect modification related to treatment cycle number. Investigating the effects of BMI on IVF-results in first treatment-cycles alone should be carried out cautiously. Public Library of Science 2016-09-21 /pmc/articles/PMC5031400/ /pubmed/27654907 http://dx.doi.org/10.1371/journal.pone.0163393 Text en © 2016 Christensen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Christensen, Mette Wulf
Ingerslev, Hans Jakob
Degn, Birte
Kesmodel, Ulrik Schiøler
Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study
title Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study
title_full Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study
title_fullStr Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study
title_full_unstemmed Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study
title_short Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study
title_sort effect of female body mass index on oocyte quantity in fertility treatments (ivf): treatment cycle number is a possible effect modifier. a register-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031400/
https://www.ncbi.nlm.nih.gov/pubmed/27654907
http://dx.doi.org/10.1371/journal.pone.0163393
work_keys_str_mv AT christensenmettewulf effectoffemalebodymassindexonoocytequantityinfertilitytreatmentsivftreatmentcyclenumberisapossibleeffectmodifieraregisterbasedcohortstudy
AT ingerslevhansjakob effectoffemalebodymassindexonoocytequantityinfertilitytreatmentsivftreatmentcyclenumberisapossibleeffectmodifieraregisterbasedcohortstudy
AT degnbirte effectoffemalebodymassindexonoocytequantityinfertilitytreatmentsivftreatmentcyclenumberisapossibleeffectmodifieraregisterbasedcohortstudy
AT kesmodelulrikschiøler effectoffemalebodymassindexonoocytequantityinfertilitytreatmentsivftreatmentcyclenumberisapossibleeffectmodifieraregisterbasedcohortstudy